NCT07690202

Brief Summary

Chronic kidney disease (CKD) affects approximately 13% of the global population. This condition is often associated with comorbidities such as diabetes and hypertension. Although its prevalence increases with age, CKD can also affect younger individuals, particularly women of childbearing age. From the early stages, CKD may lead to female-specific clinical manifestations, such as reduced fertility, occurring at a key period of life. These clinical aspects may also be accompanied by concerns about the transmission of hereditary nephropathy and may generate a significant psychological burden. However, current knowledge regarding the lived experience of young women of childbearing age with CKD remains limited, particularly in France. The main objective of this study is to explore the lived experience of young women with CKD who are not receiving kidney replacement therapy. In this study, lived experience refers to how participants perceive, make sense of, and integrate CKD into their daily lives and future life plans. Twelve participants with CKD, not transplanted and not on dialysis, will be recruited and divided into two groups: six women with genetically determined CKD and six women with non-genetic CKD. This grouping is justified by the fact that the etiology of the disease may profoundly influence lived experience. Genetic CKD is often associated with concerns regarding familial transmission and early medical follow-up, whereas non-genetic CKD may be perceived as an acquired condition occurring later in life. Data will be collected through semi-structured interviews based on a tailored interview guide. Transcripts will be analysed using Interpretative Phenomenological Analysis (IPA), which allows exploration of the meaning that each participant attributes to her experience. This is an exploratory pilot study aiming to document, for the first time in France, the lived experience of young women with CKD, with a secondary focus on the potential impact of genetic versus non-genetic etiology. Particular attention will be given to themes related to sexual and reproductive health. The findings will contribute to a better understanding of this understudied population and may ultimately improve their clinical care.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
12

participants targeted

Target at below P25 for all trials

Timeline
12mo left

Started Jun 2026

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress8%
Jun 2026Aug 2027

Study Start

First participant enrolled

June 30, 2026

Completed
1 day until next milestone

First Submitted

Initial submission to the registry

July 1, 2026

Completed
7 days until next milestone

First Posted

Study publicly available on registry

July 8, 2026

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2027

Last Updated

July 22, 2026

Status Verified

May 1, 2026

Enrollment Period

1.1 years

First QC Date

July 1, 2026

Last Update Submit

July 20, 2026

Conditions

Keywords

Chronic kidney diseaseWomen of childbearing ageLived experienceInterpretative Phenomenological Analysis (IPA)

Outcome Measures

Primary Outcomes (1)

  • Lived experience of chronic kidney disease in women of childbearing age (without renal replacement therapy)

    Exploration of participants' lived experience of CKD, including perceptions of the disease, impact on daily life, and influence on future life plans, collected through semi-structured interviews and analysed using Interpretative Phenomenological Analysis (IPA).

    Baseline (single study visit)

Secondary Outcomes (3)

  • Impact of chronic kidney disease etiology (genetic vs non-genetic) on lived experience

    Baseline (single interview)

  • Emergent themes related to sexual and reproductive health

    Baseline (single interview)

  • Health-related quality of life (KDQOL-36)

    Baseline (single interview)

Study Arms (2)

Genetic CKD group

Women of childbearing age diagnosed with chronic kidney disease (CKD) of confirmed or suspected genetic etiology, not receiving renal replacement therapy (i.e., not on dialysis orkidney transplantation).

Non-genetic CKD group

Women of childbearing age diagnosed with chronic kidney disease (CKD) of non-genetic etiology, not receiving renal replacement therapy (i.e., not on dialysis or kidney transplantation).

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Women of childbearing age with chronic kidney disease (CKD) not receiving renal replacement therapy (i.e., not on dialysis or kidney transplantation), followed at Caen University Hospital (CHU de Caen). Participants will be divided into two groups according to CKD etiology: genetic and non-genetic.

You may qualify if:

  • Women aged ≥ 18 years, cisgender, and not menopausal
  • Patients under follow-up at Caen University Hospital for chronic kidney disease
  • Patients not receiving renal replacement therapy (i.e., not on dialysis or kidney transplantation)
  • Patients who have been informed about the study and provided consent to participate

You may not qualify if:

  • Patients not covered by a national health insurance system
  • Patients under legal protection (guardianship, curatorship, or legal safeguard)
  • Patients with insufficient proficiency in French (spoken and written) to understand study information, participate in the interview, and complete the quality-of-life questionnaire
  • Patients unable to attend in-person visits at the Centre Universitaire des Maladies Rénales (CUMR)
  • Patients with comorbid conditions other than chronic kidney disease that may interfere with the study objectives (e.g. conditions affecting fertility)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Centre Universitaire des Maladies Rénales (CUMR), Caen University Hospital

Caen, 14000, France

RECRUITING

MeSH Terms

Conditions

Renal Insufficiency, Chronic

Condition Hierarchy (Ancestors)

Renal InsufficiencyKidney DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Antoine Lanot, MD

    University Hospital, Caen

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Tauc Florence, PharmD candidate

CONTACT

Antoine Lanot, MD

CONTACT

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 1, 2026

First Posted

July 8, 2026

Study Start

June 30, 2026

Primary Completion (Estimated)

August 1, 2027

Study Completion (Estimated)

August 1, 2027

Last Updated

July 22, 2026

Record last verified: 2026-05

Data Sharing

IPD Sharing
Will not share

Individual participant data will not be shared due to the sensitive and potentially identifiable nature of qualitative interview data. Participants' confidentiality will be ensured in accordance with ethical and regulatory requirements.

Locations